Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Daré Bioscience, Inc. DARE |
VANGUARD INDEX FUNDS | 254,671 3.990% |
29,641 (+13.17%) |
Filing History |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Daré Bioscience, Inc. DARE |
The Vanguard Group | 254,671 3.990% |
5,232 (+2.10%) |
Filing History |
| 2021-02-12 5:13 pm Unchanged |
2020-12-31 | 13G | Daré Bioscience, Inc. DARE |
POLARIS VENTURE PARTNERS III LP | 138,277 3.500% |
0 (Unchanged) |
Filing History |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Daré Bioscience, Inc. DARE |
The Vanguard Group | 249,440 7.880% |
249,440 (New Position) |
Filing History |
| 2021-02-09 2:25 pm Sale |
2020-12-31 | 13G | Daré Bioscience, Inc. DARE |
Hudson Bay Capital Management LP | 31,875 0.920% |
-25,000 (-43.96%) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | Daré Bioscience, Inc. DARE |
VANGUARD INDEX FUNDS | 225,030 7.110% |
225,030 (New Position) |
Filing History |